These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 24074853)

  • 21. Analysis of the Foxp3/scurfin gene in Crohn's disease.
    Park O; Grishina I; Leung PS; Gershwin ME; Prindiville T
    Ann N Y Acad Sci; 2005 Jun; 1051():218-28. PubMed ID: 16126962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in FOXO gene family and association analysis with BMI.
    Kim JR; Jung HS; Bae SW; Kim JH; Park BL; Choi YH; Cho HY; Cheong HS; Shin HD
    Obesity (Silver Spring); 2006 Feb; 14(2):188-93. PubMed ID: 16571842
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The life-extending effect of dietary restriction requires Foxo3 in mice.
    Shimokawa I; Komatsu T; Hayashi N; Kim SE; Kawata T; Park S; Hayashi H; Yamaza H; Chiba T; Mori R
    Aging Cell; 2015 Aug; 14(4):707-9. PubMed ID: 25808402
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FoxO: a new addition to the ESC cartel.
    Gonzales KA; Ng HH
    Cell Stem Cell; 2011 Sep; 9(3):181-3. PubMed ID: 21885013
    [TBL] [Abstract][Full Text] [Related]  

  • 25. FOXO3 selectively amplifies enhancer activity to establish target gene regulation.
    Eijkelenboom A; Mokry M; Smits LM; Nieuwenhuis EE; Burgering BM
    Cell Rep; 2013 Dec; 5(6):1664-78. PubMed ID: 24360957
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A single nucleotide polymorphism in the STAT5 gene favors colonic as opposed to small-bowel inflammation in Crohn's disease.
    Connelly TM; Koltun WA; Berg AS; Hegarty JP; Brinton D; Deiling S; Poritz LS; Stewart DB
    Dis Colon Rectum; 2013 Sep; 56(9):1068-74. PubMed ID: 23929016
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association between a Functional HLA-G 14-bp Insertion/deletion Polymorphism and Susceptibility to Autoimmune Diseases: A Meta-analysis.
    Lee YH; Bae SC
    Cell Mol Biol (Noisy-le-grand); 2015 Dec; 61(8):24-30. PubMed ID: 26667769
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for common genetic control in pathways of inflammation for Crohn's disease and psoriatic arthritis.
    Ho P; Bruce IN; Silman A; Symmons D; Newman B; Young H; Griffiths CE; John S; Worthington J; Barton A
    Arthritis Rheum; 2005 Nov; 52(11):3596-602. PubMed ID: 16255050
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spatial and temporal expression of FoxO transcription factors in the developing and adult murine brain.
    Hoekman MF; Jacobs FM; Smidt MP; Burbach JP
    Gene Expr Patterns; 2006 Jan; 6(2):134-40. PubMed ID: 16326148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association of FOXO3A gene polymorphisms with serum FOXO3A levels and oxidative stress markers in vitiligo patients.
    Ozel Turkcu U; Solak Tekin N; Gokdogan Edgunlu T; Karakas Celik S; Oner S
    Gene; 2014 Feb; 536(1):129-34. PubMed ID: 24333267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOXO3 determines the accumulation of α-synuclein and controls the fate of dopaminergic neurons in the substantia nigra.
    Pino E; Amamoto R; Zheng L; Cacquevel M; Sarria JC; Knott GW; Schneider BL
    Hum Mol Genet; 2014 Mar; 23(6):1435-52. PubMed ID: 24158851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rheumatoid arthritis in 2013. Translational medicine in RA: time for change.
    Miossec P
    Nat Rev Rheumatol; 2014 Feb; 10(2):74-6. PubMed ID: 24418764
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autophagy protects chondrocytes from glucocorticoids-induced apoptosis via ROS/Akt/FOXO3 signaling.
    Shen C; Cai GQ; Peng JP; Chen XD
    Osteoarthritis Cartilage; 2015 Dec; 23(12):2279-2287. PubMed ID: 26165503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Docosahexaenoic acid suppresses the expression of FoxO and its target genes.
    Chen YJ; Chen CC; Li TK; Wang PH; Liu LR; Chang FY; Wang YC; Yu YH; Lin SP; Mersmann HJ; Ding ST
    J Nutr Biochem; 2012 Dec; 23(12):1609-16. PubMed ID: 22444500
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The tumour suppressor FOXO3 is a key regulator of mantle cell lymphoma proliferation and survival.
    Obrador-Hevia A; Serra-Sitjar M; Rodríguez J; Villalonga P; Fernández de Mattos S
    Br J Haematol; 2012 Feb; 156(3):334-45. PubMed ID: 22107151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Targeting forkhead box transcription factors FOXM1 and FOXO in leukemia (Review).
    Zhu H
    Oncol Rep; 2014 Oct; 32(4):1327-34. PubMed ID: 25175498
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms of Foxp3 in patients with rheumatoid arthritis.
    Paradowska-Gorycka A; Jurkowska M; Felis-Giemza A; Romanowska-Próchnicka K; Manczak M; Maslinski S; Olesinska M
    J Rheumatol; 2015 Feb; 42(2):170-80. PubMed ID: 25448791
    [TBL] [Abstract][Full Text] [Related]  

  • 38. FoxO3 suppresses Myc-driven lymphomagenesis.
    Vandenberg CJ; Motoyama N; Cory S
    Cell Death Dis; 2016 Jan; 6(1):e2046. PubMed ID: 26764572
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of cardiomyocyte proliferation and myocardial growth during development by FOXO transcription factors.
    Evans-Anderson HJ; Alfieri CM; Yutzey KE
    Circ Res; 2008 Mar; 102(6):686-94. PubMed ID: 18218983
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Insulin-FOXO3 signaling modulates circadian rhythms via regulation of clock transcription.
    Chaves I; van der Horst GT; Schellevis R; Nijman RM; Koerkamp MG; Holstege FC; Smidt MP; Hoekman MF
    Curr Biol; 2014 Jun; 24(11):1248-55. PubMed ID: 24856209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.